Highlighted videos
HGMD
Hybrid Variant Interpretation: Combining AI + Expert Curation to Streamline...
As hereditary NGS testing grows more complex, clinical labs must interpret variants with greater speed...
QCI Interpret for Oncology
Real-World Applications of Clinical Metagenomic Sequencing in Cancer and...
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and...
QIAGEN IPA
QIAGEN IPA
IPA deeper dive: Deriving ‘omics insights without a dataset
Are you working on or planning an ‘omics project? Newsflash: You don’t need...
QIAGEN IPA
From ‘Omics to Insights Part 3: Search and Explore in IPA
This is the last part of a series that will show how you can easily turn your...
QIAGEN IPA
From ‘Omics to Insights Part 2: Interpret Your IPA Core Analysis Results
This is the second part of a series on how you can easily turn your ‘omics...
QIAGEN IPA
IPA Interpret: A hands-on workshop
Now, you can access and share the interpretative power of QIAGEN Ingenuity...
QIAGEN CLC Genomics
QIAGEN CLC Genomics
Disrupting Healthcare Using Deep Data, Remote Monitoring and AI
Today’s healthcare system largely reacts to illness rather than preventing...
QIAGEN CLC Genomics
Accelerating Viral Construct Design and QC with QIAGEN CLC Genomics Workbench
Viral constructs are essential tools for gene therapy, vaccine development...
QIAGEN CLC Genomics
Population Genetics in an Era of Genomic Health
Advances in genomic medicine hold enormous promise, but that promise cannot...
QIAGEN CLC Genomics
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN OmicSoft and Biomedical Knowledge Base
Disrupting Healthcare Using Deep Data, Remote Monitoring and AI
Today’s healthcare system largely reacts to illness rather than preventing...
QIAGEN OmicSoft and Biomedical Knowledge Base
Immunology: Guide the immunology drug discovery lifecycle with ‘omics knowledge and AI
The autoimmune drug market is dominated by blockbuster biologics, including...
QIAGEN OmicSoft and Biomedical Knowledge Base
Oncology: De-risking target evaluation and indication expansion with curated knowledge
The early stages of drug development are inherently high-risk; molecule...
QIAGEN OmicSoft and Biomedical Knowledge Base
Connecting Data to Discoveries: An Introduction to Biomedical Knowledge Graphs
Biomedical knowledge graphs are powerful tools for organizing complex...
日本語 (Japanese)
日本語 (Japanese)
01. QIAGEN OmicSoft チュートリアル1 概要
OmicSoft の概要と製品の種類についての説明です。
日本語 (Japanese)
02. QIAGEN OmicSoftチュートリアル2 起動と Land の選択
起動後、まず最初に利用するLand を選択します。
日本語 (Japanese)
03. QIAGEN OmicSoftチュートリアル3 グループ分け (Y軸の分類）
表示されているグラフのY軸は疾患の種類、喫煙歴等様々なメタデータで分類できます。
日本語 (Japanese)
04. QIAGEN OmicSoftチュートリアル4 遺伝子の検索、サンプルの絞り込み
単一遺伝子の検索、および様々なメタデータでサンプルの絞り込みを行う方法を解説します。
QCI Interpret for Oncology
QCI Interpret for Oncology
Is it oncogenic? Comparing guidelines and QCI Interpret CDS for cancer variant interpretation
Accurate clinical interpretation of somatic cancer variants is critical for...
QCI Interpret for Oncology
S2I oncology
S2I oncology
QCI Interpret for Oncology
Streamline clinical reporting for high-throughput oncology NGS testing with QCI Interpret One
With the rising demand for personalized cancer treatments, clinical...
QCI Interpret for Oncology
How to accelerate your clinical reporting workflow for high-throughput oncology NGS testing
As the demand for personalized cancer treatment grows, clinical diagnostic...
Gene Variant Databases
Gene Variant Databases
HGMD Pro in action: Search, curate and classify genetic variants - Session 1
As the use of next-generation sequencing (NGS) in diagnostics increases, so...
Gene Variant Databases
Germline and Somatic Variant Investigation using COSMIC, HGMD and QCI-IT
The accurate identification and annotation of germline and somatic variants...
Gene Variant Databases
Advances in Genomic Testing for Rare Disease Diagnostics
Over the past decade, whole-exome and whole-genome sequencing have...
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate drug targets, and accelerate early discovery
The cancer drug discovery landscape is shifting. While research continues to...
QCI Interpret for Hereditary
QCI Interpret for Hereditary
Screening 100,000 newborns using whole genome sequencing: The Genomics England Generation Study
In this on-demand recording from ACMG 2024, hear from Dr. David Bick,...
QCI Interpret for Hereditary
QCI Interpret for Hereditary Disorders
Clinical labs face significant challenges in interpreting germline variants...
QCI Secondary Analysis
QCI Secondary Analysis
How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
Next-generation sequencing (NGS) has rapidly gained popularity as a...
QCI Secondary Analysis
Introducing QCI Secondary Analysis
Introducing QCI Secondary Analysis, a new cloud-based service for NGS...
Cancer Drug Discovery
Cancer Drug Discovery
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
Cancer Drug Discovery
Targeting MUC16 Neoantigens in Pancreatic Cancer: Precision Oncology and Indication Selection
This webinar shows how we enable identification and prioritization of a novel...
Cancer Drug Discovery
Data curation as a key element in successful data science strategy
Learn the 7 habits of effective manual curation that QIAGEN Digital Insights...
Cancer Drug Discovery
Exploring drug response in low-grade glioma
This webinar introduces the Tumor Microenvironment (TME) Pathway in QIAGEN’s...
Data-Driven Drug Discovery
Data-Driven Drug Discovery
Immunology: Guide the immunology drug discovery lifecycle with ‘omics knowledge and AI
The autoimmune drug market is dominated by blockbuster biologics, including...
Data-Driven Drug Discovery
Oncology: De-risking target evaluation and indication expansion with curated knowledge
The early stages of drug development are inherently high-risk; molecule...